Get started
TUS- PHARMACEUTICATT

TUS- PHARMACEUTICA

12.03CNYD
−0.02−0.17%
As of today at 05:42 GMT
CNY
No trades
See on Supercharts
Overview
Financials
News Discussions Technicals Seasonals

000590 fundamentals

Key facts

Market capitalization‪2.94 B‬CNY
Dividend yield (indicated)—
Price to earnings Ratio (TTM)—
Basic EPS (TTM)−0.56CNY
Founded1993
Employees (FY)‪1.16 K‬
CEO—
Websitetuspharma.cn
About

Tus-Pharmaceutical Group Co., Ltd. engages in the ancient han health essence series products and chinese patent medicines. It produces oral liquids, tablets, pills, oral solutions, granules, soft plastic infusions and raw materials. Its products includes Ancient Chinese Health Essence, Danzao Oral Liquid, Danhuang Granules and Yangxin Dingpai Granules. The company was founded on March 25, 1993 and is headquartered in Hengyang, China.

Ownership
‪‪239.47 M‬‬
Free Float shares
‪‪172.41 M‬‬ (72%)
Closely held shares
‪‪67.06 M‬‬ (28%)
Free Float shares
‪‪172.41 M‬‬ (72%)
Closely held shares
‪‪67.06 M‬‬ (28%)
Capital structure
Market cap
‪‪2.94 B‬‬
Debt
‪‪171.16 M‬‬
Minority interest
‪‪2.98 M‬‬
Cash & equivalents
‪‪144.95 M‬‬
Enterprise value
‪‪2.97 B‬‬

Valuation

Fundamental metrics to determine fair value of the stock

Summary
‪‪2.94 B‬‬
Price to earning ratio (P/E)
—
Price to sales ratio (P/S)
8.92x
Market Cap
Net income
Revenue
Price to earning ratio (P/E)
—
Price to sales ratio (P/S)
8.92x
Valuation ratios
‪0.00‬
‪1.60‬
‪3.20‬
‪4.80‬
‪6.40‬
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
‪0.00‬
‪50.00‬
‪100.00‬
‪150.00‬
‪200.00‬
P/E
P/S

Growth and Profitability

Company’s recent performance and margins

Performance
‪−87%‬
‪−67%‬
‪−47%‬
‪−27%‬
‪−7%‬
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
‪‪−140.00 M‬‬
‪‪−70.00 M‬‬
‪0.00‬
‪‪70.00 M‬‬
‪‪140.00 M‬‬
Revenue
Net income
Net margin %
Revenue to profit conversion
Revenue
COGS
Gross profit
Op expenses
Op income
Non-Op income/ expenses
Taxes & Other
Net income
‪‪−22.00 M‬‬
‪0.00‬
‪‪22.00 M‬‬
‪‪44.00 M‬‬
‪‪66.00 M‬‬
Revenue
COGS
Gross profit
Expenses & adjustments
Net income
‪‪−22.00 M‬‬
‪0.00‬
‪‪22.00 M‬‬
‪‪44.00 M‬‬
‪‪66.00 M‬‬

Revenue breakdown

Revenue streams and regions a business earns money from

By source/business
Period: 2024
Chinese Medicine Health Care Production
Western Medicine Production
Other
By country
Period: 2024
China
International

Dividends

Dividend yield, history and sustainability

No dividends
000590 has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company

Debt level and coverage
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
‪‪−70.00 M‬‬
‪0.00‬
‪‪70.00 M‬‬
‪‪140.00 M‬‬
‪‪210.00 M‬‬
Debt
Free cash flow
Cash & equivalents
Financial position analysis
Short term
Long term
‪0.00‬
‪‪150.00 M‬‬
‪‪300.00 M‬‬
‪‪450.00 M‬‬
‪‪600.00 M‬‬
Assets
Liabilities